Demand For Tissue Regeneration Drives Growth In The Acellular Dermal Matrices Market
Acellular Dermal Matrices Market |
Acellular dermal matrices are
processed human or animal cadaveric skin tissues used for soft tissue
reconstruction and regeneration in patients with deep surgical wounds or burns.
These matrices act as scaffolding to encourage tissue growth and replace
excised or damaged tissue. The global acellular dermal matrices market is
gaining traction due to increasing uptake of soft-tissue reconstruction
procedures. The rapidly aging global population and rising incidence of burns
and traumatic injuries have heightened demand for effective tissue regeneration
therapies. The global Acellular Dermal Matrices Market is estimated to be
valued at US$ 8.8 Bn in 2023 and is expected to exhibit a CAGR of 18. % over
the forecast period 2023 to 2030, as highlighted in a new report published by
Coherent Market Insights.
Market key trends:
One of the key trends fueling
growth in the acellular dermal matrices market is the increasing adoption of
regenerative medicine therapies for tissue reconstruction. Regenerative
medicine aims to regenerate, repair or replace damaged cells, tissues or organs
using approaches such as tissue engineering and stem cell research. Acellular
dermal matrices are an effective regenerative medicine approach used to repair
large tissue defects by promoting the body's natural healing process. Advancements
in decellularization and 3D scaffolding technologies have broadened the
application potential of acellular matrices. Development of minimally
manipulated animal-derived matrices as well as human tissue-derived products is
also driving their adoption in tissue reconstruction procedures.
Segment Analysis
The global acellular dermal
matrices market is segmented on the basis of type, application, and end user.
The type segment is further divided into allograft and xenograft. Among these,
the allograft segment dominates the market as it provides advantages such as
biocompatibility and lower risks of disease transmission. It can be easily
integrated into the patient's body without triggering any immune response.
Key Takeaways
The Global
Acellular Dermal Matrices Market Size is expected to witness high
growth. The market size is projected to reach US$ 15.6 Bn by 2030, expanding at
a CAGR of 18%.
The North America region
currently dominates the global market and is expected to maintain its position
during the forecast period. This is attributed to rise in number of cosmetic
procedures and increasing awareness about acellular dermal matrices. Asia
Pacific is projected to be the fastest growing region due to growing medical
tourism industry in countries such as Thailand, South Korea, and India.
Key players operating in the acellular dermal matrices market are
Regenacy Pharmaceuticals, Inc., Astex Pharmaceuticals, 4SC AG, CellCentric
Ltd., Celleron Therapeutics Ltd., Bristol-Myers Squibb Company.
Get More Insights Here
https://www.newsstatix.com/acellular-dermal-matrices-market-size-share-growth-outlook-2023/
Comments
Post a Comment